An association of 5,10-Methylenetetrahydrofolate Reductase (MTHFR) gene polymorphism and ischemic stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 14, Issue 2, 2005, Pages 67-74

  Kawamoto, Ryuichi ^a   Kohara, Katsuhiko ^b   Oka, Yuichiro ^a   Tomita, Hitomi ^a   Tabara, Yasuharu ^b   Miki, Tetsuro ^b  

^a Seiyo Municipal Nomura Hospital   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gene; Homocysteine; Interaction; Polymorphism; Risk factor

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; EMBOLISM; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENOTYPE; HEART DISEASE; HEART EMBOLISM; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL MODEL;

EID: 14744300413     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2004.12.003     Document Type: Article

References (35)

1. O. Nygard, S.E. Vollset, H. Refsum Total plasma homocysteine and cardiovascular risk profile The Hordaland Homocysteine Study JAMA 274 1995 1526 1533
2. M. Ueland, H. Refsum, S.A.A. Beresford The controversy over homocysteine and cardiovascular risk Am J Clin Nutr 72 2000 324 332
3. R.D. Press, N. Beamer, A. Evans Role of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase in ischemic stroke Diagn Mol Pathol 8 1999 54 58
4. R. Kawamoto, T. Kajiwara, Y. Oka An association between plasma homocysteine concentrations and ischemic stroke in elderly Japanese J Atheroscler Thromb 9 2002 121 125
5. H. Morita, J. Taguchi, H. Kurihara Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease Circulation 95 1997 2032 2036
6. H. Morita, H. Kurihara, S. Tsubaki Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese Arterioscler Thromb Vasc Biol 18 1998 1465 1469
7. Z. Li, L. Sun, H. Zhang Multicenter Case-Control Study in China Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke A Multicenter Case-Control Study in China Stroke 34 2003 2085 2090
8. K. Kohara, M. Fujisawa, F. Ando NILS-LSA Study: MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: The NILS-LSA Study Stroke 34 2003 1130 1135
9. S. Lopaciuk, K. Bykowska, H. Kwiecinski Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke Clin Appl Thromb Hemost 7 2001 346 350
10. P.J. Kelly, J. Rosand, J.P. Kistler Homocysteine, MTHFR 677C→T polymorphism, and risk of ischemic stroke esults of a meta-analysis Neurology 59 2002 529 536
11. W.S. Aronow, C. Ahn, H. Gutstein Increased plasma homocysteine is an independent predictor of new atherothrombotic brain infarction in older persons Am J Cardiol 86 2000 585 586
12. J.W. Eikelboom, G.J. Hankey, S.S. Anand Association between high homocysteine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke Stroke 31 2000 1069 1075
13. H. Shimizu, Y. Kiyohara, I. Kato Plasma homocyst(e)ine concentrations and the risk of subtypes of cerebral infarction The Hisayama study Cerebrovasc Dis 13 2002 9 15
14. R. Kawamoto, K. Kohara, Y. Tabara An association of 5,10- methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis J Hum Genet 46 2001 506 510
15. R. Kawamoto, K. Kohara, Y. Tabara An interaction between systolic blood pressure and angiotensin-converting enzyme gene polymorphism on carotid atherosclerosis Hypertens Res 25 2002 875 880
16. Y. Chen, J. Nakura, J.J. Jin Association of the GNAS1 gene variant with hypertension is dependent on alcohol consumption Hypertens Res 26 2003 439 444
17. Z. Wu, J. Nakura, M. Abe Genome-wide linkage disequilibrium mapping of hypertension in Japan Hypertens Res 26 2003 533 540
18. J.J. Jin, J. Nakura, Z. Wu Association of angiotensin II type 2 receptor gene variant with hypertension Hypertens Res 26 2003 547 552
19. K. Yamagishi, H. Iso, T. Tanigawa High sodium intake strengthens the association between angiotensinogen T174M polymorphism and blood pressure levels among lean men and women A community-based study Hypertens Res 27 2004 53 60
20. M. Motone, T. Katsuya, K. Ishikawa Association between hepatocyte growth factor gene polymorphism and essential hypertension Hypertens Res 27 2004 247 251
21. National Institute of Neurological Disorders and Stroke Ad Hoc Committee Classification of cerebrovascular diseases Stroke 21 1990 637 676
22. Y. Tabara, K. Kohara, Y. Yamamoto Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness Hypertens Res 26 2003 677 683
23. P. Frosst, H.J. Blom, R. Milos A candidate genetic risk factor for vascular disease A common mutation in methylenetetrahydrofolate reductase Nat Genet 10 1995 111 113
24. R. Clarke, L. Daly, K. Robinson Hyperhomocysteinemia An independent risk factor for vascular disease N Engl J Med 324 1991 1149 1155
25. I.J. Perry, H. Refsum, R.W. Morris Prospective study of serum total homocysteine and risk of stroke in middle-age British men Lancet 346 1995 1395 1398
26. J.M. Bamford, C.P. Warlow Evolution and testing of the lacunar hypothesis Stroke 19 1988 1071 1082
27. K. Fassbender, O. Mielke, T. Bertsch Homocysteine in cerebral macroangiography and microangiopathy Lancet 353 1999 1586 1587
28. A.M. Engbersen, D.G. Franken, G.H. Boers Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia Am J Hum Genet 56 1995 142 150
29. A.B. Guttormsen, P.M. Ueland, I. Nesthus Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (<40μmol/L). The Hordaland homocysteine study J Clin Invest 98 1996 2174 2183
30. O. Fletcher, A.M. Kessling MTHFR association with arteriosclerotic vascular disease? Hum Genet 103 1998 11 21
31. J.M. Bamford, C.P. Warlow Evolution and testing of the lacunar hypothesis Stroke 19 1988 1074 1082
32. J.W. Heinecke, H. Rosen, L.A. Suzuki The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells J Biol Chem 262 1987 10098 10103
33. G.N. Welch, J. Loscalzo Homocysteine and atherothrombosis N Engl J Med 338 1998 1042 1050
34. R. Dardik, D. Varon, I. Tamarin Homocysteine and oxidized low-density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions Distinct mechanisms of thrombogenic modulation Thromb Haemost 83 2000 338 344
35. P. Ventura, R. Panini, M.C. Rosa Relevance of different apolipoprotein content in binding of homocysteine to plasma lipoproteins Nutr Metab Cardiovasc Dis 13 2003 218 226